z-logo
open-access-imgOpen Access
PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION
Author(s) -
M. Yu. Frolov,
В. А. Рогов
Publication year - 2016
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2016.9.1.024-032
Subject(s) - lenvatinib , sorafenib , medicine , thyroid cancer , refractory (planetary science) , oncology , cancer , physics , astrobiology , hepatocellular carcinoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here